| Tag | Content |
|---|
EnhancerAtlas ID | HS098-51316 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr7:17275120-17277380 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EN2 | MA0642.1 | chr7:17276941-17276951 | CCCAATTAGC | + | 6.02 | | RREB1 | MA0073.1 | chr7:17275420-17275440 | CCACCACACACACACACACA | + | 6.41 | | RREB1 | MA0073.1 | chr7:17275418-17275438 | CCCCACCACACACACACACA | + | 6.46 | | RREB1 | MA0073.1 | chr7:17275416-17275436 | CCCCCCACCACACACACACA | + | 6.92 | | ZNF263 | MA0528.1 | chr7:17276916-17276937 | CTCCCTCCTTTCCTCTCCTTC | - | 6.03 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_13032 | chr7:17272403-17275990 | CD34_Primary_RO01480 | | SE_13581 | chr7:17271923-17276489 | CD34_Primary_RO01536 | | SE_14238 | chr7:17272483-17276437 | CD34_Primary_RO01549 | | SE_61376 | chr7:17266224-17290689 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH07I017233 | chr7 | 17272779 | 17276245 | | GH07I017236 | chr7 | 17276329 | 17276492 |
|
Enhancer Sequence | GGTTGCAGTG AGCAGAGATC ATGCCACTGC ACTCCAGCCA AGGCAACAGA GTAAGACTCA 60
GTCTTCAAAT AAATAATTAA ATAAATAAAT AAATAAATAA ATAAATAAAA TAATGCTTTT 120
CATCTGCCAC CAGGGACCTA ATCAAAACTC TTTAATAGTT CAATGGCTTC TTGAGGACCA 180
TGACTTATTT ATTATTGTAT CTGCAGCACC CATCATGGTG CCTGACCTAC AGAATATGTT 240
CAATATGTGT TTATTGAATG AATTATAATA ATTGTGGTAT TTTTGCTTAT ATGCACCCCC 300
CCACCACACA CACACACACA CACACACACA CACACGTTAA ATCTAAAGCT TCTTGTGAGC 360
AGAAGGCTTA TCTTGTAAAT TGTTGTATCC CTAGCTCCTC GAAGGGTGTC TGGTATGATA 420
CAAACATTCA ATCATCATTT ACTGAAATGG TGAATGAAAT TCAAATGCTG GGCTTATACA 480
AGTATATGGT ATCCTCCCAT ACCTAGGTGA ACTCGTTTCT CACCACTGCC TTCCTTCCTG 540
TGAGGTGAGC CTTTGTACCA TTCGAACTCC ATGCAACTAT TCCTACCAAT TGCCTCATAT 600
GAACTACCTC ACACAAACCA CTGCCTACTT AAATTCTATC CTCCTTTAAG GCCCAACTGA 660
AGTCACATTC TGTTCACAAA TGAGACTTCT TGACTCCTTC AGCCCTCACA GATCTTCATG 720
TCATCCAGAC TCAGAGTACC TATGGCCTTT ACTCAGATTT GTCCCTACAG ACTCATTCTT 780
CCATTGTTTG CCTCCTTTTA AATTCCTGGG TGATGTTATC TATTTCCTTC ACTTTGGCAT 840
CTCTCACATG TTAATGCCAC CACACTCCTT CATCTCGGGC CCTGATCTCA GAGCATCAAA 900
ACTCATTGTT TCGCAAGTCC TCAGGCTCAA AAATGTTAAG TGAGTTCATG TTTTTCGATT 960
CTGAAGGTAT GTTCATTGTA TTGTTTTTGT CATAATGAGT CTTTTTGCCT TTAGCGTATA 1020
TATGAAAATA CTTGTGGATG AAACGATATG CTATCTCAAA TTTATTTCAA AATAACGTGG 1080
GAGGAGATAA AATAAAGTGG GTATATTATT CTATCTCTTA TTATATGTGC TTGAACTTTT 1140
TCATAAGTTT TTAAAAACTT TTGTTTTCCT CAATCATCAC CTTCCATCAC TTTGAACCTG 1200
CTCTTCTTTT GCTTAAATGC ATCACTGTCC CCTGCATCCC AACTTTCTGG GACACTCACC 1260
AGGGGAAAAC AGAGATTGAC ATGTGAAGCT GAGTCAATTC AGTTGCTCAT GACATAAGTG 1320
GTTGAGTAGA AGATACTGGT GCCAAGCCAA ACATTTTTTT TTATTTTTTT GAAACAAAGG 1380
GACCATCTAT ATTTTTTAAA GAAAAATAAG AGAGCTGAGT TATCCTGCCA CCCCACAATG 1440
TTTCCAACTT TGTGACTCTC TAAAAAGAAG ACAAGAGAAC ATCCCAAATC CACGGTTCTG 1500
TTGTTTCCTT TTGTGAACCA CCTTTCCCTT TTCTCATCTA CTTAGAAACC ATCTACTGAA 1560
GCTTTGAGAT TCTGCTCAAC CATCATCCTG TCTGTTGTAT TCCTGAATCT CTGTCTCCCA 1620
TAGGCAGAAT CAAATACTTT TTCATTGAAA TTCCTACAGG ACATTATACC CACTTGCTTT 1680
TTTAGTACTC ACTGTGGAAT ATAAGTTATT AGTTTACATG TGTTCGGCAT TGTGCTGATG 1740
TGGATGGAGA ACTAACTTAG GTCATCTCCC CAAAACTCTA ACCTCTGAGT TTTCCTCTCC 1800
CTCCTTTCCT CTCCTTCATA CCCCAATTAG CATAGTGTAT TGGAAAAAGT GGATGTTCAA 1860
TGAAAGTTTG AAATGAATCA GACAGAATCT AATTTCTTCA TATTTGTTGC TCCTTTTTTC 1920
TCCTAATATT CATACATCAA GTCTTCTTTC CTAATCTCCC CAACCCAAAA GGGCTCCTTC 1980
TTCTGAACTC ACAATTTTTT TTTTTTTTTG AGATAATGTC TTGCTCTCTT GCCCAGTGGG 2040
GAGTGCAGAG GCACAATCTC GGCTCACTGC GACATCCGCC TCCCAGTTCA AGCGATTCTT 2100
GTGCCTCAGA CTCCTGAGTA GCTGGGATTA CAGGCATGTG CTCTCAGACC CGGCTAATTT 2160
TTGTAATTTT AGTTGAAACA GGGTTTTGCC ATGTTGATTA GGTTGGTCTC GAACTCCCGC 2220
CTCAAGTGAT CCGCCCACCT TGGCCTCCCA AAGTTCTGTG 2260
|
